CME Group Heading Into Q3 With Solid Results But No Clear Re-Rating Catalyst (NASDAQ:CME)
· seekingalpha.com
CME Group (CME) delivers strong volumes, recurring revenue and margins, but premium valuation caps upside.
CME Group ( CME ) heads toward its Q3 2026 earnings report in the same spot I pointed out last time : the company keeps running things well, operationally and f...